Impact of pharmaceutical teleconsultation on glycemic control of people with type 2 diabetes mellitus in a public pharmacy in Brazil: A randomized clinical trial protocol (TelePharmaceutical Care Diabetes Trial) – TPCDT

Authors

  • Agnes Nogueira Gossenheimer Department of Pharmaceutical Assistance of the Secretary of State for Health of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
  • Fernanda Fávero Alberti Department of Pharmaceutical Assistance of the Secretary of State for Health of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
  • Vanessa Klimkowski Argoud Department of Pharmaceutical Assistance of the Secretary of State for Health of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
  • Diego da Silva Gouvea Multiprofessional Residency in Health at Grupo Hospitalar Conceição, Porto Alegre, Rio Grande do Sul, Brazil
  • Thales Preissler Department of Pharmaceutical Assistance of the Secretary of State for Health of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
  • Roberto Eduardo Schneiders Ministry of Health of Brazil, Porto Alegre, Rio Grande do Sul, Brazil
  • Ana Paula Rigo Department of Pharmaceutical Assistance of the Secretary of State for Health of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
  • Beatriz D’Agord Schaan School of Medicine, Endocrine, Hospital de Clínicas de Porto Alegre and Federal University of Rio Grande do Sul, Rio Grande do Sul, Brazil

DOI:

https://doi.org/10.14295/bjs.v2i5.292

Keywords:

telehealth, pharmaceutical care, diabetes mellitus, pharmaceutical services, tele-interventions

Abstract

Telepharmacy is a fundamental tool to ensure glycemic control in patients who don’t access health services. The objective of this protocol is to report the procedures of a randomized clinical trial that will evaluate the impact and economic evaluation of a pharmaceutical teleconsultation service for patients using dapagliflozin, recently incorporated by the Brazilian public health system for the treatment of type 2 diabetes (T2D). Patients aged 65 years or older, with T2D, and who withdraw dapagliflozin in a public pharmacy located in southern Brazil will be recruited. They will be electronically randomized with allocation for intervention or control group. The intervention will be conducted out through three teleconsultations, one per month, with a pharmacist. The main outcomes will be glycemic control (hemoglobin A1c) and treatment adherence. Secondary outcomes will include lipid profile, blood pressure, and body mass index, number of hospital admissions, number of emergency room visits, number of medical consultations performed, number of problems related to pharmacotherapy identified and resolved, cost related to service and quality of life. The economic evaluation will be carried out using time-driven activity-based costing. Through this research, we will be able to identify whether pharmaceutical teleconsultation services can complement face-to-face consultations to improve health outcomes in T2D patients on dapagliflozin. The study was registered in Clinical Trials (NCT05380596).

References

Alessi, J., de Oliveira, G. B., Franco, D. W., Becker, A. S., Knijnik, C. P., Kobe, G. L., ... & Telo, G. H. (2021). Telehealth strategy to mitigate the negative psychological impact of the COVID-19 pandemic on type 2 diabetes: A randomized controlled trial. Acta Diabetol, 58(7), 899-909. https://doi.org/10.1007/s00592-021-01690-1 DOI: https://doi.org/10.1007/s00592-021-01690-1

Alessi, J., Telo, G. H., de Oliveira, G. B., Schneiders, J., Zanella, M. J. B., & Schaan, B. D. (2021). The rational treatment of diabetes mellitus in older adults: The adequacy of treatment decisions based on individualized glycemic targets in primary and tertiary care. J Diabetes Complications, 35(4). https://doi.org/10.1016/j.jdiacomp.2020.107835. DOI: https://doi.org/10.1016/j.jdiacomp.2020.107835

American Diabetes Association (2018). Economic costs of diabetes in the US in 2017. Diabetes care, 41(5), 917–928. DOI: https://doi.org/10.2337/dci18-0007

American Diabetes Association (2019). Standards of medical care in diabetes—2019 abridged for primary care providers. Clinical diabetes: a publication of the American Diabetes Association, 1(11). https://doi.org/10.2337/cd18-0105. DOI: https://doi.org/10.2337/cd18-0105

Ben, A. J., Neumann, C. R., & Mengue, S. S (2012). Teste de Morisky-Green e Brief Medication Questionnaire para avaliar adesão a medicamentos. Revista de Saúde Pública, 46, 279-289. https://doi.org/10.1590/S0034-89102012005000013 DOI: https://doi.org/10.1590/S0034-89102012005000013

Brasil (2020). Ministério da Saúde. Secretaria De Ciência, Tecnologia, Inovação E Insumos Estratégicos. Portaria Sctie/Ms Nº 54, De 11 de Novembro de 2020. Aprova o Protocolo Clínico e Diretrizes Terapêuticas do Diabete Melito Tipo 2. Brasília - DF: 2020. Available in: < https://www.gov.br/conitec/pt-br/midias/protocolos/20201113_pcdt_diabete_melito_tipo_2_29_10_2020_final.pdf> Access on: 20 dec. 2022.

Brasil (2020). Ministério da Saúde. Portaria nº 16, de 29 de abril de 2020. Torna pública a decisão de incorporar a dapagliflozina para o tratamento de diabetes mellitus tipo 2 e de não incorporar a empagliflozina para o tratamento de diabetes mellitus tipo 2, no âmbito do Sistema Único de Saúde – SUS. Diário Oficial da União. Brasília - DF: 2020. Available in: < https://brasilsus.com.br/index.php/pdf/portaria-no-16-4/> Access on: Nov 24, 2022.

Chan, A. W., Tetzlaff, J. M., Altman, D. G., Dickersin, K., & Moher, D (2013). SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet, 381. https://doi.org/10.1016/S0140-6736(12)62160-6 DOI: https://doi.org/10.1016/S0140-6736(12)62160-6

Charles, B. L (2000). Telemedicine can lower costs and improve access. Healthcare Financial Management, 54(4), 66-66.

Conselho Federal de Farmácia – CFF (2022). Resolução nº 727 de 30 de junho de 2022. Dispõe sobre a regulamentação da telefarmácia. Diário Oficial da União: Brasília - DF, 2022. Available in: https://www.legisweb.com.br/legislacao/?id=434209. Access on: 02 sep. 2022.

Correr, C. J., Pontarolo, R., Melchiors, A. C., Rossignoli, P., Fernández-Llimós, F., & Radominski, R. B (2008). Tradução para o português e validação do instrumento Diabetes Quality of Life Measure (DQOL-Brasil). Arquivos Brasileiros de Endocrinologia & Metabologia, 52, 515-522. https://doi.org/10.1590/S0004-27302008000300012 DOI: https://doi.org/10.1590/S0004-27302008000300012

Eberle, C., & Stichling, S (2021). Clinical improvements by telemedicine interventions managing type 1 and type 2 diabetes: systematic meta-review. Journal of medical Internet research, 23(2), 23244. https://doi.org/10.2196/23244 DOI: https://doi.org/10.2196/23244

Elliott, R. A., Boyd, M. J., Salema, N. E., Davies, J., Barber, N., Mehta, R. L., ... & Craig, C (2016). Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service. BMJ quality & safety, 25(10), 747-758. https://doi.org/10.1136/bmjqs-2015-004400. DOI: https://doi.org/10.1136/bmjqs-2015-004400

Elliott, R. A., Tanajewski, L., Gkountouras, G., Avery, A. J., Barber, N., Mehta, R., ... & Waring, J (2017). Cost effectiveness of support for people starting a new medication for a long-term condition through community pharmacies: an economic evaluation of the new medicine service (NmS) compared with normal practice. Pharmacoeconomics, 35(12), 1237-1255. https://doi.org/10.1007/s40273-017-0554-9 DOI: https://doi.org/10.1007/s40273-017-0554-9

Garcia, S. P., Madalosso, M. M., Bottino, L. G., Monteiro, L. E., Sparrenberger, K., Schneiders, J., ... & Schaan, B. D. (2022). Optimization of Care for Adult Outpatients With Type 2 Diabetes Through the Diabetes Self-Management Multidisciplinary Program: A Randomized Clinical Trial. Can J Diabetes, 46(5), 449-456.e3. https://doi.org/10.1016/j.jcjd.2022.01.006 DOI: https://doi.org/10.1016/j.jcjd.2022.01.006

Gossenheimer, A. N., Argoud, V. K., Rojas, C. C., Alberti, F. F., & Schneiders, R. E (2021). Planejamento estratégico de um serviço de telecuidado farmacéutico para pacientes com asma: um estudo de implementação. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 12 (3), 654-654. https://doi.org/10.30968/rbfhss.2021.123.0654 DOI: https://doi.org/10.30968/rbfhss.2021.123.0654

Gossenheimer, A. N., Rigo, A. P., & Schneiders, R. E (2021). Organização do serviço de telecuidado farmacêutico como estratégia de combate à covid-19 no Rio Grande do Sul. REAd. Revista Eletrônica de Administração (Porto Alegre), 26 (1), 524-535. https://doi.org/10.1590/1413-2311.293.109474. DOI: https://doi.org/10.1590/1413-2311.293.109474

Hanjani, L. S., Caffery, L. J., Freeman, C. R., Peeters, G., & Peel, N. M (2020). A scoping review of the use and impact of telehealth medication reviews. Research in Social and Administrative Pharmacy, 16(8), 1140-1153. https://doi.org/10.1016/j.sapharm.2019.12.014 DOI: https://doi.org/10.1016/j.sapharm.2019.12.014

Joiner, K. L., Nam, S., & Whittemore, R (2017). Lifestyle interventions based on the diabetes prevention program delivered via eHealth: a systematic review and meta-analysis. Preventive medicine, 10, 194-207. https://doi.org/10.1016/j.ypmed.2017.04.033 DOI: https://doi.org/10.1016/j.ypmed.2017.04.033

Kaplan, R. S (2014). Improving value with TDABC. Healthcare Financial Management, 68 (6), 76-84. Available in: https://pubmed.ncbi.nlm.nih.gov/24968629/. Access on: 10 may 2022.

Lovic, D., Piperidou, A., Zografou, I., Grassos, H., Pittaras, A., & Manolis (2020). A. The growing epidemic of diabetes mellitus. Current vascular pharmacologym 18 (2), 104-109. https://doi.org/10.2174/1570161117666190405165911. DOI: https://doi.org/10.2174/1570161117666190405165911

Oh, J. A., Kim, H. S., Yoon, K. H., & Choi, E. S (2003). A telephone-delivered intervention to improve glycemic control in type 2 diabetic patients. Yonsei medical journal, 44 (1), 1-8. https://doi.org/10.3349/ymj.2003.44.1.1. DOI: https://doi.org/10.3349/ymj.2003.44.1.1

Omboni, S., Tenti, M., & Coronetti, C. (2019). Physician–pharmacist collaborative practice and telehealth may transform hypertension management. Journal of human hypertension, 33 (3), 177-187. https://doi.org/10.1038/s41371-018-0147-x DOI: https://doi.org/10.1038/s41371-018-0147-x

Pharmaceutical Care Network Europe Association (PCNE) (2020). The PCNE Classification, v 9.1. 2020. Available in: https://www.pcne.org/upload/files/417_PCNE_classification_V9-1_final.pdf. Access on: 15 may 2022.

Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., ... & IDF Diabetes Atlas Committee. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 157, 107843. https://doi.org/10.1016/j.diabres.2019.107843 DOI: https://doi.org/10.1016/j.diabres.2019.107843

Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Journal of Pharmacology and pharmacotherapeutics, 1(2), 100-107. DOI: https://doi.org/10.4103/0976-500X.72352

Sharp, L. K., Biggers, A., Perez, R., Henkins, J., Tilton, J., & Gerber, B. S (2021). A Pharmacist and Health Coach–Delivered Mobile Health Intervention for Type 2 Diabetes: Protocol for a Randomized Controlled Crossover Study. JMIR research protocols, 10(3), 17170. https://doi.org/10.2196/17170 DOI: https://doi.org/10.2196/17170

Sociedade Brasileira de Diabetes (2022). Diretrizes da Sociedade Brasileira de Diabetes. Clannad Editora Científica. Available in: https://diretriz.diabetes.org.br/. Access on: 10 aug. 2022.

Teló, G. H., Cureau, F. V., de Souza, M. S., Andrade, T. S., Copês, F., & Schaan, B. D (2016). Prevalence of diabetes in Brazil over time: a systematic review with meta-analysis. Diabetology & metabolic syndrome, 8(1), 1-13. https://doi.org/10.1186/s13098-016-0181-1 DOI: https://doi.org/10.1186/s13098-016-0181-1

Teló, G. H., Iorra, F. D. Q., Velho, B. S., Sparrenberger, K., & Schaan, B. D (2020). Validation to Brazilian Portuguese of the Self-Care Inventory-revised for adults with type 2 diabetes. Archives of Endocrinology and Metabolism, 64, 190-194. https://doi.org/10.20945/2359-3997000000213 DOI: https://doi.org/10.20945/2359-3997000000213

Tuckson, R. V., Edmunds, M., & Hodgkins, M. L (2017). Telehealth. New England Journal of Medicine, 377(16), 1585-1592. https://doi.org/10.1056/NEJMsr1503323 DOI: https://doi.org/10.1056/NEJMsr1503323

Zhang, X., Bullard, K. M., Gregg, E. W., Beckles, G. L., Williams, D. E., Barker, L. E., ... & Imperatore, G. (2012). Access to health care and control of ABCs of diabetes. Diabetes care, 35(7), 1566-1571. https://doi.org/10.2337/dc12-0081 DOI: https://doi.org/10.2337/dc12-0081

Downloads

Published

2023-05-01

How to Cite

Gossenheimer, A. N., Alberti, F. F., Argoud, V. K. ., Gouvea, D. da S., Preissler, T., Schneiders, R. E., Rigo, A. P., & Schaan, B. D. (2023). Impact of pharmaceutical teleconsultation on glycemic control of people with type 2 diabetes mellitus in a public pharmacy in Brazil: A randomized clinical trial protocol (TelePharmaceutical Care Diabetes Trial) – TPCDT. Brazilian Journal of Science, 2(5), 58–69. https://doi.org/10.14295/bjs.v2i5.292

Issue

Vol. 2 No. 5 (2023): Brazilian Journal of Science

Section

Health Sciences

License

Copyright (c) 2023 Agnes Nogueira Gossenheimer, Fernanda Fávero Alberti, Vanessa Klimkowski Argoud, Diego da Silva Gouvea, Thales Preissler, Roberto Eduardo Schneiders, Ana Paula Rigo, Beatriz D’Agord Schaan

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.